Associated Papers
A Global Perspective of GBA1-Related Parkinson's Disease: A Narrative Review.
Koros C et al.
Genes, 2024
The Genetic Etiology of Parkinson's Disease Does Not Robustly Affect Subthalamic Physiology.
Weill C et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2023
Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations.
Macías-García D et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2022
34859503 (PubMed )
Supplement: supplement_1.docx
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.
Behl T et al.
Translational Neurodegeneration, 2021
Longitudinal Positron Emission Tomography of Dopamine Synthesis in Subjects with GBA1 Mutations.
Lopez G et al.
Annals of Neurology, 2020
A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
Aflaki E et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2016
Greater risk of parkinsonism associated with non-N370S GBA1 mutations.
Barrett MJ et al.
Journal of Inherited Metabolic Disease, 2013
Select a paper to view details